Men's Health: What experts say you should do if you’re exposed to the coronavirus
UC infectious disease expert says it's best to keep your distance
Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases was interviewed by Men's Health magazine for a story on steps people should take if they think they've been exposed to the coronavirus.
Dr. Carl Fichtenbaum in a lab in the UC College of Medicine Division of Infectious Diseases. Photo/Joe Fuqua II/UC Creative + Brand
Dr. Fichtenbaum said that even if you're not sure, but suspect via the primary symptoms—fever, cough and shortness of breath—it's best to distance yourself and stay in quarantine.
"This is where we have to look towards the greater good of humanity," he says. "If most of us use this strategy—we can beat this virus." Read the full article here.
Men's Health also featured Dr. Fichtenbaum in an article on the claims that ibuprofen is unsafe for people with COVID-19.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.
Using GLP-1s for weight loss, maintenance after bariatric surgery
March 5, 2026
Bariatric surgery has become a cornerstone treatment for severe obesity and its related comorbidities, offering superior long-term efficacy compared with lifestyle and pharmacologic interventions alone. Yet persistent clinical gaps remain in a subset of patients, including insufficient weight loss and postoperative weight regain.
'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment
February 26, 2026
The results of a clinical trial involving the University of Cincinnati, recently published in The New England Journal of Medicine, show people failing HIV treatments with oral medications were able to be treated successfully using injections.